Screener
Aardvark Therapeutics, Inc. AARD Q2 2026 earnings
Reported August 11, 2026 · After market close
EPS-$0.66Beat by $0.21
EPS estimate-$0.87
Next report
Nov 12, 2026 (in a month)EPS estimate-$0.74
Versus estimates
Diluted EPS
FAQ
- When did Aardvark Therapeutics, Inc. report Q2 2026 earnings?
- Aardvark Therapeutics, Inc. (AARD) reported Q2 2026 earnings on August 11, 2026 after market close.
- What were Aardvark Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Aardvark Therapeutics, Inc. reported eps of $-0.66 for Q2 2026.
- Did Aardvark Therapeutics, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.87 by $0.21.
- How did Aardvark Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 0.0% from $-0.66.
- Where can I find Aardvark Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-344978) and the 10-Q periodic report (0001193125-26-344987) directly on SEC EDGAR. The filing index links above go to sec.gov.
